New Content  edit
Get The App!

 

CME/CE Certified On-Demand
Lecture Series

Upcoming Lectures

There are no meetings currently scheduled in this subject area.
If you are interested in this topic and would like a meeting scheduled in your local area please request a lecture by clicking the button above.
|
Speaker:
Topic:
Format:
Date:
Time:
Location:
Accreditation:



Available Topics


Time is Brain in the Management of Hemorrhagic Strokes

Learning Objectives
  • Discuss the risk factors for DOAC-related bleeding, as well as the appropriate diagnosis and monitoring of a bleeds
  • Identify the severity of a bleeding event and the need for treatment with a reversal strategy
  • Clearly demonstrate good understanding of when to initiate an anticoagulation reversal strategy
  • Educate clinicians on the importance of time management relative to transferring a patient from a community-based hospital to a stroke center, in hopes of improving outcomes

Case Studies in Hemorrhagic Stroke Management - What Should be Done?


Learning Objectives
  • Clearly demonstrate good understanding of when to initiate an anticoagulation reversal strategy
  • Implement, based on guidelines, treatment recommendations in patients with major bleeding
  • Identify the severity of a bleeding event and the need for treatment with a reversal strategy

The Importance and Value of Comprehensive Stroke Centers


Learning Objectives
  • Educate clinicians on the importance of time management relative to transferring a patient from a community-based hospital to a stroke center, in hopes of improving outcomes
  • Delineate between drip and ship strategy vs. mothership strategy

Managing Intracranial Hemorrhages in the Presence of Anticoagulation


Learning Objectives
  • Review the latest clinical guidelines and trial data directing DOAC use
  • Implement, based on guidelines, treatment recommendations in patients with major bleeding
  • Discuss the latest trial data directing DOAC use
  • Distinguish between the various outcomes in the RE-VERSE AD and ANNEXA trials, and understand the relationship with hemostasis


Accreditation Information

Joint Accreditation Statement
In support of improving patient care, these activities have been planned and implemented by the Postgraduate Institute for Medicine and Total CME.  Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates each live activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education
Postgraduate Institute for Medicine designates each continuing education activity for 0.5 contact hour (0.05 CEUs) of the Accreditation Council for Pharmacy Education.

Time is Brain in the Management of Hemorrhagic Strokes - UAN: JA4008162-9999-20-906-L01-P; 0.5 contact hour; Activity Type: Knowledge
Case Studies in Hemorrhagic Stroke Management – What Should Be Done? - UAN: JA4008162-9999-20-907-L01-P; 0.5 contact hour; Activity Type: Knowledge
The Importance and Value of Comprehensive Stroke Centers - UAN: JA4008162-9999-20-959-LO1-P; 0.5 contact hour; Activity Type: Knowledge
Managing Intracranial Hemorrhages in the Presence of Anticoagulation - UAN: JA4008162-9999-20-960-L01-P; 0.5 contact hour; Activity Type: Knowledge

Continuing Nursing Education
The maximum number of hours awarded for each Continuing Nursing Education activity is 0.5 contact hour.

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Target Audience
These activities have been designed to meet the educational needs of physicians, registered nurses, pharmacists and other healthcare professionals involved in the care of patients with hemorrhagic strokes and referral of patients to stroke centers.

Fee Information
There is no fee for these educational activities.

Jointly provided by Postgraduate Institute for Medicine and Total CME

These activities are supported by an independent educational grant from Portola Pharmaceuticals, Inc.



Available Formats

At this time, all IMPACT Live events are available as a webinar. Please check the scheduled lectures tab to register for upcoming events.

Pre-work Program/ Post-work Quiz
Live events utilize a closed-loop learning experience by providing pre-work programs and post-work quizzes to accompany the lecture events to ensure attendees of the lectures retain concepts taught. The flipped classroom pre-work episodes are developed specifically to introduce key information which may be applied during the live event and encourage engagement between the attendee and faculty. Pre-work is presented by expert faculty in several short, educational episodes. Post-work quizzes allow attendees to revisit topics for a better long-term retention and test their knowledge on concepts taught at the lecture.

Compliance with Sunshine Act
The National Physician Payment Transparency Program (Sunshine Act) is a section of the Patient Protection and Affordable Care Act of 2010 that requires pharmaceutical and medical device companies to report to the Federal government certain payments (e.g. meals and other meeting expenses) they make to physicians and teaching hospitals. IMPACT Live programs fully comply with the Sunshine Act and, as a result, payments may be reportable based upon these requirements. For detailed information, please visit www.cms.gov.



IMPACT Stroke Faculty


Program Chairs:

Mark J. Alberts, MD
Physician-in-Chief
Neuroscience Institute, Hartford HealthCare
Chief, Department of Neurology
Hartford Hospital, Hartford, CT

Michel T. Torbey, MD
Professor of Neurology
Chairman, Neurology Department
University of New Mexico, Albuquerque, NM


Faculty:

Michael Abraham, MD
Associate Professor
University of Kansas Medical Center
Kansas City, KS

Jonathan Bui, MD, PhD
Professor of Neurosciences
UC San Diego Medical Center
San Diego, CA

Ira Chang, MD
Medical Director, Neurocritical Care
Swedish Medical Center
Founding Partner – Blue Sky Neurology PC LLC
Englewood, CO

James Grotta, MD
Neurologist, Memorial Hermann Medical Group
Director of Stroke Research, Clinical Institute for Research and Innovation
Memorial Hermann – Texas Medical Center
Houston, TX

David S. Liebeskind, MD
Professor of Neurology
UCLA Department of Neurology
Director, Neurovascular Imaging Research Core
Director, UCLA Comprehensive Stroke Center
Los Angeles, CA

Anmar Razak, MD
Associate Professor, Chief – Division of Cerebrovascular Diseases and Neuro-Interventional Surgery
Michigan State University
East Lansing, MI

Fred Rincon, MD, MSc, MBE
Division Head, Cerebrovascular Disease – Farber Institute Neuroscience
Associate Professor of Neurology and Neurological Surgery
Thomas Jefferson University
Philadelphia, PA

Shlee S. Song, MD
Associate Professor, Department of Neurology
Director, Stroke Program at Cedars-Sinai Medical Center
Director, Stroke Program at Torrance Memorial Medical Center
Director, Telestroke Program
Los Angeles, CA